跳至主要内容
临床试验/NCT04490668
NCT04490668已完成不适用

Association of Human Albumin With Anastomotic Leakage After Gastric Cancer Surgery

Ruijin Hospital0 个研究点目标入组 1,049 人开始时间: 2016年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,049
主要终点
Comparison of the rate of anastomotic leakage

研究概览

简要总结

We investigate whether the intravenously administered human albumin is beneficial to prevent anastomotic leakage after gastric cancer surgery.

详细描述

Anastomotic leakage after gastric cancer surgery is not very common but it is a very critical postoperative complication. Anastomotic leakage severely compromises the recovery after surgery. It increases the overall burden of patients and hospital resources. Postoperative mortality is higher in patients with anastomotic leakage.

Human albumin is routinely administered after surgery with a unproven hypothesis that the human albumin is beneficial to prevent anastomotic leakage. We investigate whether the intravenously administered human albumin is beneficial to prevent anastomotic leakage after gastric cancer surgery.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Histologically confirmed gastric cancer
  • Patients who underwent radical gastrectomy

排除标准

  • Patient who did not undergo gastrectomy

结局指标

主要结局

Comparison of the rate of anastomotic leakage

时间窗: Up to one months after the discharge of last patient

The rate of anastomotic leakage were compared among both groups

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

BIRENDRA KUMAR SAH

Principal investigator

Ruijin Hospital

相似试验